Study shows that gut microbiota produced compounds during fermentation of insoluble fiber from dietary plant matter doesn't affect the ability of the coronavirus to enter and replicate in cells lining the intestines. But, in vitro treatment of cells with these molecules reduces the expression of a gene that plays a key role in viral cell entry and a cytokine receptor that favors inflammation.
Up to 50% of COVID-19 patients (17.6% of severe cases) experience gastrointestinal symptoms like diarrhea, vomiting, and abdominal pain....
Study shows that gut microbiota produced compounds during fermentation of insoluble fiber from dietary plant matter doesn't affect the ability of the coronavirus to enter and replicate in cells lining the intestines. But, in vitro treatment of cells with these molecules reduces the expression of a gene that plays a key role in viral cell entry and a cytokine receptor that favors inflammation.
Up to 50% of COVID-19 patients (17.6% of severe cases) experience gastrointestinal symptoms like diarrhea, vomiting, and abdominal pain....